Kanabo Group Plc (LON:KNB)
0.2250
-0.0750 (-25.00%)
Apr 30, 2025, 4:20 PM BST
Heartland Financial USA Revenue
Kanabo Group had revenue of 694.00K GBP in the half year ending June 30, 2024, with 190.38% growth. This brings the company's revenue in the last twelve months to 1.14M, up 40.22% year-over-year. In the year 2023, Kanabo Group had annual revenue of 895.00K with 48.42% growth.
Revenue (ttm)
1.14M
Revenue Growth
+40.22%
P/S Ratio
1.25
Revenue / Employee
57.00K
Employees
20
Market Cap
1.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 895.00K | 292.00K | 48.42% |
Dec 31, 2022 | 603.00K | 530.00K | 726.03% |
Dec 31, 2021 | 73.00K | 13.00K | 21.67% |
Dec 31, 2020 | 60.00K | -22.12K | -26.94% |
Dec 31, 2019 | 82.12K | 28.14K | 52.13% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |